Deciphera Pharmaceuticals, Inc. (DCPH)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 11.84 |
| Open | 11.95 |
| Bid | 10.05 x 1000 |
| Ask | 12.29 x 800 |
| Day's Range | 11.54 - 12.09 |
| 52 Week Range | 6.51 - 38.91 |
| Volume | |
| Avg. Volume | 1,295,742 |
| Market Cap | 776.719M |
| Beta (5Y Monthly) | 1.40 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.90 |
| Earnings Date | Aug 01, 2022 - Aug 05, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.78 |
- Simply Wall St.
We Think Deciphera Pharmaceuticals (NASDAQ:DCPH) Needs To Drive Business Growth Carefully
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Zacks
Deciphera (DCPH) Down Despite Narrower-Than-Expected Q1 Loss
Deciphera (DCPH) reports narrower-than-expected loss in the first quarter of 2022 while revenues beat estimates.
- Zacks
Puma Biotech (PBYI) Q1 Earnings Beat, Nerlynx Sales Fall Y/Y
Puma Biotech (PBYI) Q1 loss narrows while sales come in line with estimates. PBYI's stock declines in the after-market trading session following the news.
© 2022 Yahoo. All rights reserved.
